For those wishing to invest in 3-D bioprinting, Organovo Holdings, Inc. (ONVO 5.23%) is the only pure play in town. Organovo currently bioprints and markets human tissues as a means of accelerating ...
SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel ...
In the first half of 2017, Amgen (NASDAQ: AMGN) paid out 140 times more in dividends to its shareholders than Organovo Holdings (NASDAQ: ONVO) made in revenue -- during its entire history as a company ...
Human kidney tissue. Image source: Getty Images. Is 3D bioprinting poised to take off in a major way? Organovo Holdings (NASDAQ: ONVO) thinks the answer is "yes." The company is a leader in 3D ...
Drug discovery company Viscient Biosciences said on Wednesday it has formally proposed a merger with another San Diego company, Organovo Holdings. Organovo “bioprints” liver and other organ tissue for ...
Organovo designs and create functional human tissues using our proprietary three-dimensional bioprinting technology. Their goal is to build living human tissues that are proven to function like native ...
Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) -Organovo Holdings' experimental drug reduced liver fat by as much as 22.8% in a mid-stage study of some patients with ...
Organovo Holdings ($ONVO), which has focused its bioprinting technology on fabricating synthetic tissue for testing, said it plans to develop 3D-bioprinted human ...
SAN DIEGO--(BUSINESS WIRE)--Organovo Holdings, Inc. (“Organovo”) (Nasdaq: ONVO) convened, on March 26, 2020, the special meeting of stockholders (the “Special Meeting”) and then adjourned the Special ...
For those wishing to invest in 3-D bioprinting, Organovo Holdings, Inc. is the only pure play in town. Organovo currently bioprints and markets human tissues as a means of accelerating preclinical ...
These charts show why this 3D bioprinting leader's stock is doing well and could enjoy even more success in the years to come. After a few terrible years, 2016 is looking very good for Organovo stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results